{"id":6370,"date":"2023-01-26T08:51:31","date_gmt":"2023-01-25T23:51:31","guid":{"rendered":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/?post_type=results&p=6370"},"modified":"2023-01-26T16:24:27","modified_gmt":"2023-01-26T07:24:27","slug":"2022%e5%b9%b4%e3%80%80%e3%81%9d%e3%81%ae2%ef%bc%88%e5%ad%a6%e4%bc%9a%e7%99%ba%e8%a1%a8%e3%80%81%e8%ac%9b%e6%bc%94%e3%80%81%e7%a0%94%e7%a9%b6%e5%8a%a9%e6%88%90%e3%80%81%e5%8f%97%e8%b3%9e%ef%bc%89","status":"publish","type":"results","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/results\/6370\/","title":{"rendered":"2022\u5e74\u3000\u305d\u306e2\uff08\u5b66\u4f1a\u767a\u8868\u3001\u8b1b\u6f14\u3001\u7814\u7a76\u52a9\u6210\u3001\u53d7\u8cde\uff09"},"content":{"rendered":"

2022\u5e74\u696d\u7e3e\u3000\u305d\u306e2
\n\u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09<\/a>
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/a>
\n\u25a0 \u8b1b\u6f14<\/a>
\n\u25a0 \u7814\u7a76\u52a9\u6210<\/a>
\n\u25a0 \u53d7\u8cde<\/a>
\n\u8ad6\u6587\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f2022\u5e74\u696d\u7e3e\u3000\u305d\u306e1<\/a>\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002<\/p>\n

\u25a0<\/span> \u5b66\u4f1a\u767a\u8868(\u56fd\u5185)<\/strong>
\n\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a(\u5168\u56fd)<\/p>\n

1. \u8d64\u5742\u5320.\u4e09\u6728\u5747.\u4e95\u4e0a\u6b66.\u77f3\u4e38\u826f\u5e83.\u9ad9\u6a4b\u5fe0\u7ae0.\u6751\u4e0a\u5fe0\u53f8.\u68ee\u5343\u5c0b.\u4ed6. \u975e\u5178\u578b\u7684\u306a\u753b\u50cf\u6240\u898b\u3092\u4f34\u3063\u305fLangerhans\u7d30\u80de\u7d44\u7e54\u7403\u75c7\u306e\u4e00\u4f8b.\u7b2c51\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a(2022.2\uff0c\u6771\u4eac)<\/p>\n

2. \u5ca9\u91ce\u7965\u5b50,\u3000\u5e73\u7530\u96c5\u662d,\u3000\u4e2d\u6751\u8aa0\u6cbb,\u3000\u8d64\u5b97\u660e\u4e45,\u3000\u4ed6.\u3000\u7d4c\u76ae\u7d4c\u809d\u7684\u585e\u6813\u8853\u304c\u594f\u529f\u3057\u305f\u4eba\u5de5\u809b\u9580\u9759\u8108\u7624\u51fa\u8840\u306e1\u4f8b.\u3000\u7b2c51\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a\uff082022. 6,\u3000\u5175\u5eab\uff09<\/p>\n

3. \u5ca9\u91ce\u7965\u5b50,\u3000\u5e73\u7530\u96c5\u662d,\u3000\u4ed6.\u3000PTO\u304c\u594f\u529f\u3057\u305f\u4eba\u5de5\u809b\u9580\u9759\u8108\u7624\u51fa\u8840\u306e\uff11\u4f8b.\u3000\u7b2c29\u56de\u65e5\u672c\u9580\u8108\u5727\u4ea2\u9032\u75c7\u5b66\u4f1a\u7dcf\u4f1a\uff082022. 9,\u3000\u5927\u962a\uff09<\/p>\n

4. \u5ca1\u7530\u77e5\u4e45, \u5ddd\u53e3\u76f4\u4eba, \u5bae\u5ddd\u6b63\u7537, \u5c0f\u5ddd\u907c, \u7530\u9089\u88d5\u8cb4, \u4e2d\u6751\u58ee\u5fd7, \u677e\u7530\u5353\u4e5f, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1. \u534a\u5c0e\u4f53PET\/CT\u306b\u304a\u3051\u308b\u5fc3\u7b4b\u306e\u751f\u7406\u7684\u96c6\u7a4d\u306e\u691c\u8a3c. \u7b2c\uff18\uff11\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082022.4, \u6a2a\u6d5c\uff09<\/p>\n

5. \u5ca1\u7530\u77e5\u4e45, \u5ddd\u53e3\u76f4\u4eba, \u5bae\u5ddd\u6b63\u7537, \u5c0f\u5ddd\u907c, \u7530\u908a\u88d5\u8cb4, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1. \u30c7\u30b8\u30bf\u30ebPET\u3068\u5f93\u6765\u578bPET\u306b\u304a\u3051\u308b\u5fc3\u623f\u751f\u7406\u7684\u96c6\u7a4d\u306e\u6bd4\u8f03. \u7b2c\uff13\uff12\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a(2022.6 \u6771\u4eac)<\/p>\n

6. \u5ca1\u7530\u77e5\u4e45, \u5ddd\u53e3\u76f4\u4eba, \u5bae\u5ddd\u6b63\u7537, \u5b88\u5c4b\u5065, \u4e2d\u585a\u8aa0, \u5927\u897f\u606d\u5e73, \u77f3\u6751\u96bc\u4eba, \u57ce\u6238\u8f1d\u4ec1.\u30c7\u30b8\u30bf\u30ebPET\u306b\u304a\u3051\u308b\u524d\u7acb\u817aFDG\u96c6\u7a4d\u306e\u691c\u8a0e. \u7b2c\uff16\uff12\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2022.9 \u4eac\u90fd\uff09<\/p>\n

7. \u5ddd\u53e3\u76f4\u4eba\u3001\u5bae\u5ddd\u6b63\u7537\u3001\u5ca1\u7530\u77e5\u4e45\u3001\u57ce\u6238\u8f1d\u4ec1. \u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u5fc3\u7b4b\u30d6\u30ea\u30c3\u30b8\u306b\u3088\u308b\u865a\u8840\u304cCT-SPECT fusion \u753b\u50cf\u3067\u660e\u77ad\u306b\u63cf\u51fa\u3055\u308c\u305f\u75c7\u4f8b \u7b2c32\u56de \u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u5b66\u4f1a\u7dcf\u4f1a (2022.6, \u6771\u4eac)<\/p>\n

8. Kawaguchi N, Miyagawa M, Matsuoka M, Okada T, Kido Te. Clinical Impact of Digital PET\/CT for Initial Staging of Cancer Compared to Conventional PET\/CT \u7b2c81\u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2022.4, \u6a2a\u6d5c)<\/p>\n

9. Kawaguchi N, Miyagawa M, Okada T, Kido Te. Direct Comparison between Digital and Conventional PET\/CT in Patients with Malignant Tumor \u7b2c62\u56de \u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2022.9, \u4eac\u90fd)<\/p>\n

10. \u6cb3\u5185 \u5b5d\u7bc4, \u7530\u9089 \u88d5\u8cb4, \u7d30\u5ddd \u8cb4\u6676, \u5c71\u672c \u96c4\u592a, \u5409\u7530 \u548c\u6a39, \u798f\u5c71 \u76f4\u7d00, \u677e\u7530 \u5353\u4e5f, \u5ddd\u53e3 \u76f4\u4eba, \u57ce\u6238 \u502b\u4e4b, \u57ce\u6238 \u8f1d\u4ec1. \u5fc3\u7b4bCT perfusion\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u865a\u8840\u8a3a\u65ad\u306b\u304a\u3051\u308bmyocardial enhancement ratio to aorta\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066. \u7b2c32\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff082022. 5, \u6771\u4eac\uff09<\/p>\n

11. \u6cb3\u5185\u7fa9\u5f18, \u974d\u5ca1\u614e\u592a\u90ce, \u9ad8\u7530\u7d00\u5b50, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u57ce\u6238\u8f1d\u4ec1. \u9ad8\u9f62\u8005\u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u6210\u7e3e\u306e\u691c\u8a0e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff082022. 11, \u5e83\u5cf6\uff09<\/p>\n

12. \u5c0f\u6797\u7950\u4ecb\uff0c\u68ee\u5ddd\u53cb\u90ce\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4ed6\uff0e\u76f4\u8178\u764c\u8853\u5f8c\u306b\u51fa\u73fe\u3057\u305f\uff0c\u5897\u5927\u3059\u308b\u813evascular lesion\u306e\uff11\u4f8b\uff0e\u7b2c35\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a\uff082022.6.24-25, \u9ad8\u77e5\uff09<\/p>\n

13. \u5c0f\u6797\u7950\u4ecb\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4ed6\uff0e\u5f8c\u9838\u9593\u9699\u816b\u7624\u3092\u5951\u6a5f\u306b\u767a\u898b\u3055\u308c\u305f\uff0c\u8853\u524d\u306b\u539f\u767a\u5de3\u3092\u540c\u5b9a\u3057\u5f97\u306a\u304b\u3063\u305f\u4e2d\u54bd\u982d\u764c\u306e1\u4f8b. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a (2022.9.2-4, \u6771\u4eac\uff0cHybrid)<\/p>\n

14. \u5c0f\u6797\u7950\u4ecb\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4ed6\uff0e\u80c3\u7570\u6240\u6027\u81b5\u4eee\u6027\u56a2\u80de\u306e\u9577\u671f\u7d4c\u904e\u89b3\u5bdf\u4e2d\u306b\u767a\u751f\u3057\u305f\u81b5\u764c\u306e1\u4f8b. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a (2022.9.2-4, \u6771\u4eac\uff0cHybrid)<\/p>\n

15. \u9152\u4e95\u4f38\u4e5f\uff0c\u5c0f\u6797\u7950\u4ecb\uff0c\u68ee\u5ddd\u53cb\u90ce\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u83c5\u539f\u656c\u6587\uff0eFDG-PET\/CT\u306e\u60aa\u6027\u816b\u760d\u8a3a\u65ad\u80fd\u3078\u306e\u6162\u6027\u9ad8\u8840\u7cd6\u306e\u5f71\u97ff\uff0e\u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082022.4.14-17\uff0c\u6a2a\u6d5c\uff0cHybrid\uff09<\/p>\n

16. \u6e05\u6c34\u8f1d\u5f66\uff0c\u5c0f\u6797\u7950\u4ecb\uff0c\u68ee\u5ddd\u53cb\u90ce\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587, \u4ed6\uff0eBRCA1\/2\u75c5\u7684\u30d0\u30ea\u30a2\u30f3\u30c8\u3092\u6709\u3059\u308b\u4e73\u764c\u60a3\u8005\u306b\u304a\u3051\u308bMRI\u6240\u898b\u3001\u30de\u30f3\u30e2\u30b0\u30e9\u30d5\u30a3\u6240\u898b\u3068\u75c5\u7406\u6240\u898b\u306e\u691c\u8a0e\uff0e\u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082022.4.14-17\uff0c\u6a2a\u6d5c\uff0cHybrid\uff09<\/p>\n

17. \u9ad8\u9580\u653f\u5609\u3001\u57ce\u6238\u502b\u4e4b\u3001\u5c0f\u5ddd\u3000\u907c\u3001\u4e2d\u6751\u58ee\u5fd7\u3001\u57ce\u6238\u8f1d\u4ec1. 2D-LGE \u6cd5\u3068 image-based navigation(iNAVI) 3D-LGE \u6cd5\u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c94\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2022.1,Web)<\/p>\n

18. \u9ad8\u9580\u653f\u5609\u3001\u57ce\u6238\u502b\u4e4b\u3001\u5c0f\u5ddd\u3000\u907c\u3001\u4e2d\u6751\u58ee\u5fd7\u3001Jianing pang\u3001\u5c0f\u68ee\u82b3\u79cb\u3001\u57ce\u6238\u8f1d\u4ec1. Free-Breathing Cardiac Cine MRI with Compressed Sensing Real-Time Imaging and Retrospective Motion Correction(RTCS cine MoCo) \u3068\u606f\u6b62\u3081\u5f93\u6765\u6cd5cine\u306b\u304a\u3051\u308b\u5de6\u5ba4\u5fc3\u6a5f\u80fd\u89e3\u6790\u306e\u6bd4\u8f03\u691c\u8a0e \u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2022.4,\u6a2a\u6d5c\/\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9)<\/p>\n

19. \u9ad8\u9580\u653f\u5609\u3001\u57ce\u6238\u502b\u4e4b\u3001\u5c0f\u5ddd\u3000\u907c\u3001Jianing Pang\u3001\u5c0f\u68ee\u82b3\u79cb\u3001\u57ce\u6238\u8f1d\u4ec1. FBCS cine MoCo \u3068\u606f\u6b62\u3081\u5f93\u6765\u6cd5 cine \u306b\u304a\u3051\u308b\u5de6\u5ba4\u5fc3\u7b4b strain \u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a(2022.9,\u540d\u53e4\u5c4b\/\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9)<\/p>\n

20. \u9ad8\u7530\u7d00\u5b50, \u5bae\u5ddd\u6b63\u7537, \u5ca1\u7530\u77e5\u4e45, \u5ddd\u53e3\u76f4\u4eba, \u6cb3\u5185\u7fa9\u5f18, \u974d\u5ca1\u614e\u592a\u90ce, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u57ce\u6238\u8f1d\u4ec1. \u7532\u72b6\u817a\u764c\u653e\u5c04\u6027\u30e8\u30fc\u30c9\u5185\u7528\u7642\u6cd5\u6642\u306e\u8840\u6e05\u96fb\u89e3\u8cea\u6fc3\u5ea6\u306b\u95a2\u9023\u3059\u308b\u56e0\u5b50\u306e\u691c\u8a0e. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u671f\u81e8\u5e8a\u5927\u4f1a (2022. 9, \u6771\u4eac)<\/p>\n

21. \u9ad8\u7530\u7d00\u5b50, \u5bae\u5ddd\u6b63\u7537, \u5ca1\u7530\u77e5\u4e45, \u5ddd\u53e3\u76f4\u4eba, \u77f3\u5ddd\u6d69\u53f2, \u974d\u5ca1\u614e\u592a\u90ce, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u57ce\u6238\u8f1d\u4ec1. Effect of difference in preparation method for radioactive iodine on serum electrolytes. \u7b2c62\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2022. 9, \u4eac\u90fd)<\/p>\n

22. Yuki Tanabe, Tomoyuki Kido, Ryo Ogawa, Masashi Nakamura, Teruhito Kido. Feature-tracking strain derived from compressed sensing cine cardiovascular magnetic resonance imaging for assessment of heart failure with preserved ejection fraction \u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082022\u5e744\u6708\u3000\u6a2a\u6d5c\uff09<\/p>\n

23. \u974d\u5ca1\u614e\u592a\u90ce\u3001\u6cb3\u5185\u7fa9\u5f18\u3001\u9ad9\u7530\u7d00\u5b50\u3001\u4e0a\u6d25\u5b5d\u592a\u90ce\u3001\u57ce\u6238\u8f1d\u4ec1\uff0eHPV\u967d\u6027\u4e2d\u54bd\u982d\u764c\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u6210\u7e3e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff082022. 11, \u5e83\u5cf6\uff09<\/p>\n

24. \u5e74\u68ee \u4e98, \u677e\u7530 \u6075, \u6d25\u7530 \u5b5d\u6cbb, \u6d77\u8001\u539f \u308b\u3044, \u5c0f\u6797 \u5f69, \u57ce\u6238 \u8f1d\u4ec1. Conspicuity and detectability for focal liver lesions in hepatobiliary phase images using compressed sensing reconstruction with variable compressed sensing factors.\u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a(2022.4,\u6a2a\u6d5c)<\/p>\n

25. \u5e74\u68ee \u4e98, \u677e\u7530 \u6075, \u6d77\u8001\u539f \u308b\u3044, \u6d25\u7530 \u5b5d\u6cbb, \u57ce\u6238 \u8f1d\u4ec1. \u7279\u5fb4\u7684\u306a\u753b\u50cf\u6240\u898b\u3092\u5448\u3057\u305f\u814e\u7c98\u6db2\u7ba1\u72b6\u7d21\u9318\u7d30\u80de\u764c\u306e1\u4f8b. \u7b2c35\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.<\/p>\n

26. \u5e74\u68ee \u4e98, \u4e2d\u6751 \u58ee\u5fd7. \u4e2d\u67a2\u795e\u7d4c\u7cfb\u539f\u767a\u60aa\u6027\u9ed2\u8272\u816b\u306e\u4e00\u4f8b. \u7b2c42\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7.<\/p>\n

27. \u9577\ufa11\u6167, \u795e\ufa11\u535a\u5145, \u7267\u7530\u61b2\u4e8c, \u6ff1\u672c\u6cf0. \u5b50\u5bae\u981a\u764c\u6839\u6cbb\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u81a3\u6669\u671f\u6709\u5bb3\u4e8b\u8c61\u306e\u691c\u8a0e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a (2022. 11\u3000\u5e83\u5cf6)<\/p>\n

28. \u6771\u91ce \u535a\u3001\u5c71\u672c \u79c0\u4e5f\u3001\u85e4\u672c \u9032\u4e00\u90ce\u3001\u6a2a\u5c71 \u96c4\u4e00\u90ce\u3001\u5713\u672c \u525b\u3001\u85e4\u679d \u88d5\u4e4b\u3001\u963f\u90e8 \u5145\u4f2f. \u80f8\u90e8CT\u306b\u3088\u308b\u51a0\u52d5\u8108\u77f3\u7070\u5316\u306e\u7c21\u6613\u8a55\u4fa1\u6cd5. \u7b2c63\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a\u30012022\u5e7410\u670828\u65e5\u3001\u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\u30ce\u30fc\u30b9.<\/p>\n

29. \u798f\u5c71\u76f4\u7d00, \u7530\u4e2d\u5b8f\u660e, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u8f1d\u4ec1. \u81ea\u7136\u9589\u585e\u3057\u305f\u9aa8\u76e4\u5185\u52d5\u9759\u8108\u5947\u5f62\u306e1\u4f8b. \u7b2c51\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a\uff082022.6, \u795e\u6238\uff09<\/p>\n

30. \u5e73\u585a\u7fa9\u5eb7, \u4e09\u6728\u3000\u5747, \u6e21\u90e8\u771f\u5fd7, \u6728\u982d\u514b\u5df1. low grade B-cell lymphoma (primary CNS marginal zone B-cell lymphoma)\u306e\u4e00\u4f8b. \u7b2c42\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7. (2022. 7, \u5c0f\u6a3d)<\/p>\n

31. \u7267\u7530\u61b2\u4e8c\u3001\u6ff1\u672c\u6cf0\u3001\u795e\u5d0e\u535a\u5145\u3001\u9577\u5d0e\u6167. \u4e0a\u54bd\u982d\u764cIMRT\u5f8c\u306e\u6b7b\u56e0\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c35\u56de\u3000\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\uff082022\u5e743\u6708\u3000\u611b\u77e5\uff09<\/p>\n

32. \u7267\u7530\u61b2\u4e8c\u3001\u6ff1\u672c\u6cf0\u3001\u795e\u5d0e\u535a\u5145\u3001\u9577\u5d0e\u6167\u3001\u7fbd\u85e4\u76f4\u4eba\u3001\u57ce\u6238\u8f1d\u4ec1. Predictors of weight loss during intensity-modulated radiotherapy in patients with head and neck squamous cell carcinoma. \u7b2c81\u56de\u3000\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082022\u5e744\u6708\u3000\u795e\u5948\u5ddd\uff09<\/p>\n

33. \u7267\u7530\u61b2\u4e8c\u3001\u6ff1\u672c\u6cf0\u3001\u9577\u5d0e\u6167\u3001\u795e\u5d0e\u535a\u5145. \u80ba\u764c\u9aa8\u8ee2\u79fb\u306e\u5c40\u6240\u5236\u5fa1\u3068\u4e88\u5f8c\u306e\u95a2\u4fc2. \u7b2c58\u56de\u3000\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff082022\u5e749\u6708\u3000\u6771\u4eac\uff09<\/p>\n

34. \u7267\u7530\u61b2\u4e8c\u3001\u6ff1\u672c\u6cf0\u3001\u9577\u5d0e\u6167\u3001\u795e\u5d0e\u535a\u5145\u3001\u6210\u672c\u52dd\u5e83. \u7de9\u548c\u30b1\u30a2\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3078\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u533b\u53c2\u52a0\u306e\u5f79\u5272. \u7b2c35\u56de\u3000\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a \u5b66\u8853\u5927\u4f1a\uff082022\u5e7411\u6708\u3000\u5e83\u5cf6\uff09<\/p>\n

35. \u5c71\u672c\u5c1a\u5e78\uff0e\u30aa\u30f3\u30b5\u30a4\u30c8\u533b\u7642\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u4e8b\u6545\u30fb\u707d\u5bb3\u533b\u5b66\u4f1a\uff082022 .9\uff0e\u677e\u5c71\uff09<\/p>\n

36. \u5c71\u672c\u5c1a\u5e78\uff0e\u88ab\u3070\u304f\u533b\u7642\u65b0\u7814\u4fee\u4f53\u5236\uff5e\u57fa\u790e\u7814\u4fee\u5b9f\u65bd\u6a5f\u95a2\u306e\u7acb\u5834\u304b\u3089. \u65e5\u672c\u653e\u5c04\u7dda\u4e8b\u6545\u30fb\u707d\u5bb3\u533b\u5b66\u4f1a\uff082022 .9\uff0e\u677e\u5c71\uff09<\/p>\n

37. \u6a2a\u4e95\u656c\u5f18,\u3000\u77f3\u4e38\u826f\u5e83,\u3000\u6751\u7530\u4eae\u6d0b,\u3000\u591a\u4fdd\u5eb7\u5e73,\u3000\u798f\u5c71\u76f4\u7d00,\u3000\u5ddd\u53e3\u76f4\u4eba,\u3000\u6751\u4e0a\u5fe0\u53f8,\u3000\u4e95\u4e0a\u6b66,\u3000\u4e09\u6728\u5747.\u3000\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u809d\u8ee2\u79fb\u306b\u5bfe\u3059\u308b\u7d4c\u76ae\u7684\u809d\u52d5\u8108\u5316\u5b66\u585e\u6813\u8853\u306e\u6cbb\u7642\u6210\u7e3e\u304a\u3088\u3073\u4e88\u5f8c\u306b\u95a2\u3059\u308b\u691c\u8a0e.\u3000\u7b2c51\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a\uff082022. 6,\u3000\u5175\u5eab\uff09<\/p>\n

38. \u6a2a\u4e95\u656c\u5f18,\u3000\u77f3\u4e38\u826f\u5e83,\u3000\u798f\u5c71\u76f4\u7d00,\u3000\u5ca9\u91ce\u7965\u5b50,\u3000\u5ddd\u53e3\u76f4\u4eba,\u3000\u5e73\u585a\u7fa9\u5eb7,\u3000\u4e95\u4e0a\u6b66.\u3000\u4e73\u764c\u5c40\u6240\u518d\u767a\u75c5\u5909\u304b\u3089\u306e\u6301\u7d9a\u6027\u51fa\u8840\u306b\u5bfe\u3057\u7d4c\u30ab\u30c6\u30fc\u30c6\u30eb\u7684\u52d5\u8108\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b.\u3000\u7b2c11\u56de\u7de9\u548cIVR\u7814\u7a76\u4f1a\uff082022. 10,\u3000\u5175\u5eab\uff09<\/p>\n

39. Kazuki Yoshida, Yuki Tanabe, Takanori Kouchi, Natsumi Kuwahara, Takaaki Hosokawa, Yuta Yamaoto, Naoki Fukuyama, Takuya Matsuda, Tomoyuki Kido, Teruhito Kido. The Comparison of the Diagnostic Performance Between Dynamic CTP and Static CTP for Detecting Obstructive Coronary Artery Disease: Pilot study. \u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2022.4. \u6a2a\u6d5c)<\/p>\n

40. \u4e0a\u7530\u4eae\u3001\u5c71\u7e23\u6587\u3001\u4ec1\u4e95\u7530\u308a\u3061\u3001\u4ec1\u4e95\u7530\u660e\u3001\u4e09\u6751\u5c07. \u62e1\u6563\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u7528\u3044\u305f\u5168\u8133\u767d\u8cea\u8def\u89e3\u6790\u3088\u308b\u53cc\u6975\u6027\u969c\u5bb3\u306e\u75c5\u614b\u89e3\u660e. \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\uff082022.9\uff0c\u611b\u77e5\uff09<\/p>\n

 <\/p>\n

\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/p>\n

1. \u8d64\u5742\u5320.\u6a2a\u4e95\u656c\u5f18.\u897f\u5c71\u9999\u5b50.\u5c0f\u6797\u5f69.\u9db4\u5ca1\u5e78\u592a.\u5ca9\u91ce\u7965\u5b50.\u5ca1\u7530\u52a0\u5948\u5b50.\u68ee\u5343\u5c0b.\u5e73\u585a\u7fa9\u5eb7.\u6751\u4e0a\u5fe0\u53f8.\u77f3\u4e38\u826f\u5e83.\u4e95\u4e0a\u6b66.\u4ed6. \u53f3\u80ba\u4e0b\u8449\u539f\u767a\u306e\u7dda\u6bdb\u6027\u7c98\u6db2\u7d50\u7bc0\u6027\u4e73\u982d\u72b6\u816b\u760d\u306e\u4e00\u4f8b. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a (2022.12\uff0c\u5fb3\u5cf6)<\/p>\n

2. \u4e95\u624b\u9999\u5948. G-CSF\u7523\u751f\u80ba\u764c\u306e1\u4f8b. \u7b2c36\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082022.9, WEB\uff09<\/p>\n

3. \u6d66\u5ca1\u5927\u77e5.\u80c3\u816b\u7624\u306e\u4e00\u4f8b.\u7b2c39\u56de\u9053\u5f8c\u8179\u90e8\u753b\u50cf\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9(2022.5, \u611b\u5a9b)<\/p>\n

4. \u5927\u539f\u5065\u592a\u90ce, \u5409\u7530\u548c\u6a39, \u7d30\u5ddd\u8cb4\u6676, \u5317\u6751\u62d3\u4e5f, \u6851\u539f\u5948\u6d25\u7f8e, \u5ca1\u7530\u77e5\u4e45, \u5c71\u672c\u96c4\u592a, \u7530\u908a\u88d5\u8cb4, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u5bae\u5ddd\u6b63\u7537, \u57ce\u6238\u8f1d\u4ec1. \u5fc3\u4e0d\u5168\u75c7\u72b6\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3055\u308c\u305f\u5fc3\u81d3\u539f\u767a\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2022.12,\u5fb3\u5cf6)<\/p>\n

5. \u5ca1\u7530\u77e5\u4e45, \u5ddd\u53e3\u76f4\u4eba, \u5bae\u5ddd\u6b63\u7537, \u5409\u7530\u548c\u6a39, \u5c0f\u5ddd\u907c, \u7530\u9089\u88d5\u8cb4, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1. \u534a\u5c0e\u4f53PET\/CT\u306b\u304a\u3051\u308b\u5927\u8840\u7ba1\u708e\u306e\u8a55\u4fa1. \u7b2c45\u56de\u3057\u307e\u306a\u307f\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9(2022.11\u4eca\u6cbb)<\/p>\n

6. \u83ca\u6c60\u7fd4\u592a, \u5409\u7530\u548c\u6a39, \u5e74\u68ee\u4e98, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1. \u81e8\u5e8a\u7d4c\u904e\u3092\u89b3\u5bdf\u3057\u5f97\u305fMVNT\uff08multinodular and vacuolating neuronal tumor of the cerebrum\uff09\u7591\u3044\u306e\u4e8c\u4f8b. \u7b2c136\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2022.6\u3000\u5e83\u5cf6)<\/p>\n

7. \u83ca\u6c60\u9686\u5fb3\uff0c\u5b89\u539f\u7f8e\u6587\uff0e\u5f53\u9662\u306b\u304a\u3051\u308bVSRAD advance2\u3068BAAD\u306e\u6bd4\u8f03\uff0e\u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082022.12\uff0c\u5fb3\u5cf6\uff09<\/p>\n

8. \u6cb3\u5185\u7fa9\u5f18, \u974d\u5ca1\u614e\u592a\u90ce, \u9ad8\u7530\u7d00\u5b50, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u57ce\u6238\u8f1d\u4ec1. \u5b50\u5bae\u4f53\u764c\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u6210\u7e3e\u306e\u691c\u8a0e. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082022. 12, \u5fb3\u5cf6\uff09<\/p>\n

9. \u5c0f\u6797\u5f69\uff0c\u5ca1\u7530\u52a0\u5948\u5b50\uff0c\u68ee\u5343\u5c0b\uff0c\u8d64\u5742\u5320\uff0c\u9db4\u5ca1\u5e78\u592a\uff0c\u5ca9\u91ce\u7965\u5b50\uff0c\u6a2a\u4e95\u656c\u5f18\uff0c\u897f\u5c71\u9999\u5b50\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u6751\u4e0a\u5fe0\u53f8\uff0c\u77f3\u4e38\u826f\u5e83\uff0c\u4e95\u4e0a\u6b66\uff0e\u809d\u539f\u767alipoblastoma\u306e1\u4f8b\uff0e\u7b2c136\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082022.6\uff0c\u5e83\u5cf6\uff09<\/p>\n

10. \u5c0f\u6797\u5f69\uff0c\u9db4\u5ca1\u5e78\u592a\uff0c\u5e73\u585a\u7fa9\u5eb7\uff0c\u4e95\u4e0a\u6b66\uff0e\u7cd6\u5c3f\u75c5\u6027\u30b1\u30c8\u30a2\u30b7\u30c9\u30fc\u30b7\u30b9\u306b\u7d9a\u767a\u3057\u3066\u4e0d\u6b63\u6027\u5668\u51fa\u8840\u3092\u6765\u3057\u305f1\u4f8b\uff0e\u7b2c10\u56de\u4e2d\u56fd\u30fb\u56db\u56fdGUR\u7814\u7a76\u4f1a\uff082022.6\uff0c\u5ca1\u5c71\uff09<\/p>\n

11. \u5c0f\u6797\u5f69\uff0c\u4e95\u4e0a\u6b66\uff0e\u5a66\u4eba\u79d1\u4ed8\u5c5e\u5668\u816b\u7624\u306e\u9451\u5225\uff0e\u7b2c11\u56de\u4e2d\u56fd\u30fb\u56db\u56fdGUR\u7814\u7a76\u4f1a\uff082022.11\uff0cweb\uff09<\/p>\n

12. \u5c0f\u6797\u7950\u4ecb\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u68ee\u5ddd\u53cb\u90ce\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u4ed6\uff0e\u80f8\u58c1\u816b\u7624\u3092\u5951\u6a5f\u306b\u767a\u898b\u3055\u308c\u305f\u5375\u5de3\u764c\u306e1\u4f8b\uff0e\u7b2c136\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2022.6.17-18, \u5e83\u5cf6, Hybrid)<\/p>\n

13. \u5c0f\u6797\u7950\u4ecb\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u4ed6\uff0e\u591a\u767a\u80ba\u7d50\u7bc0\u3068\u3057\u3066\u8a8d\u3081\u3089\u308c\u305f\u810a\u7d22\u816b\u306e\uff11\u4f8b\uff0e\u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2022.12.3-4, \u5fb3\u5cf6)<\/p>\n

14. \u9ad8\u9580\u653f\u5609\u3001\u57ce\u6238\u502b\u4e4b\u3001\u5c0f\u5ddd\u3000\u907c\u3001\u4e2d\u6751\u58ee\u5fd7\u3001\u57ce\u6238\u8f1d\u4ec1. Free-Breathing Cardiac Cine MRI with Compressed Sensing Real-Time Imaging and Retrospective Motion Correction\u3068\u606f\u6b62\u3081\u5f93\u6765\u6cd5cine\u306b\u304a\u3051\u308b\u5de6\u5ba4\u5fc3\u6a5f\u80fd\u89e3\u6790\u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c44\u56de\u3057\u307e\u306a\u307f\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2022.6,\u4eca\u6cbb\/\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9)<\/p>\n

15. \u9ad9\u6a4b\u5ba3\u8cb4, \u677e\u7530\u6075, \u6d66\u5ca1\u5927\u77e5, \u5e74\u68ee\u4e98, \u6d25\u7530\u5b5d\u6cbb, \u57ce\u6238\u8f1d\u4ec1, \u4ed6. ICPN(intracholecystic papillary neoplasm) with associated invasive carcinoma\u306e\u4e00\u4f8b. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2022.12,\u5fb3\u5cf6)<\/p>\n

16. \u7af9\u672c\u62d3\u6b63\u3001\u8d8a\u667a\u4ec1\u7f8e\u3001\u68b6\u539f\u8aa0\u3001\u6e21\u90e8\u7b11\u9e97\u3001\u4e09\u597d\u88d5\u7f8e\u3001\u5c0f\u7530\u5c1a\u543e\u3001\u6d66\u5cf6\u96c4\u4ecb\u3001\u677e\u7530\u5065\u3001\u83ca\u6c60\u6075\u4e00\uff0e\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u7537\u6027SPN\u306e3\u75c7\u4f8b\uff0e\u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082022.12\u6708\uff09<\/p>\n

17. \u591a\u4fdd\u5eb7\u5e73, \u4e09\u6728\u5747, \u9752\u91ce\u7965\u53f8. \u9580\u8108\u30ac\u30b9\u8840\u75c7\u3092\u4f34\u3063\u305f\u80c3\u58c1\u5185\u6c17\u816b\u306e2\u4f8b. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u30fb\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\uff082022.12. \u5fb3\u5cf6\uff09<\/p>\n

18. \u5fb3\u6c38\u4f38\u5b50\uff0c\u5c0f\u6797\u7950\u4ecb\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587, \u4ed6\uff0eFDG PET\/CT\u3067\u5de8\u5927\u8102\u80aa\u8089\u816b\u306b\u3088\u308bNICTH\u304c\u7591\u308f\u308c\u305f1\u4f8b\uff0e\u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2022.6.18, \u5e83\u5cf6, Hybrid)<\/p>\n

19. \u6771\u91ce \u535a\u3001\u5c71\u672c \u79c0\u4e5f\u3001\u85e4\u672c \u9032\u4e00\u90ce\u3001\u85e4\u4e95 \u9686\u3001\u963f\u90e8 \u5145\u4f2f. \u80f8\u90e8CT\u306b\u3088\u308b\u51a0\u52d5\u8108\u77f3\u7070\u5316\u306e\u7c21\u6613\u8a55\u4fa1\u6cd5 – \u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76 -. \u7b2c136\u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\u30012022\u5e746\u670817\u65e5\u3001\u5e83\u5cf6\u770c\u533b\u5e2b\u4f1a\u9928.<\/p>\n

20. \u6771\u91ce \u535a\u3001\u5c71\u672c \u79c0\u4e5f\u3001\u963f\u90e8 \u5145\u4f2f. \u80f8\u90e8CT\u306b\u3088\u308b\u51a0\u52d5\u8108\u77f3\u7070\u5316\u306e\u7c21\u6613\u8a55\u4fa1\u6cd5 – \u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76 -. \u7b2c35\u56de\u611b\u5a9b\u653e\u5c04\u7dda\u79d1\u533b\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a\u30012022\u5e7410\u670822\u65e5\u3001\u611b\u5a9b\u770c\u533b\u5e2b\u4f1a\u9928.<\/p>\n

21. \u7d30\u5ddd\u6d69\u5e73\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u5c0f\u6797\u7950\u4ecb\uff0c\u4ed6\uff0e\u524d\u7acb\u817a\u764c\u6cbb\u7642\u7d4c\u904e\u4e2d\u306b\u51fa\u73fe\u3057\u305f\u76f4\u8178\u809b\u9580\u90e8\u7121\u8272\u7d20\u6027\u60aa\u6027\u9ed2\u8272\u816b\u306e\uff11\u4f8b\uff0e\u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a (2022.12.3-4, \u5fb3\u5cf6)<\/p>\n

22. \u7267\u7530\u61b2\u4e8c\u3001\u6ff1\u672c\u6cf0\u3001\u9577\u5d0e\u6167\u3001\u795e\u5d0e\u535a\u5145. \u80c3\u764c\u51fa\u8840\u306b\u5bfe\u3059\u308b\u7de9\u548c\u7167\u5c04. \u7b2c136\u56de\u3000\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u3000\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082022\u5e746\u6708\u3000\u5e83\u5cf6\uff09<\/p>\n

23. \u7267\u7530\u61b2\u4e8c\u3001\u6ff1\u672c\u6cf0\u3001\u9577\u5d0e\u6167\u3001\u795e\u5d0e\u535a\u5145\u3001\u6a4b\u6839\u52dd\u7fa9. \u524d\u7acb\u817a\u5c0f\u7d30\u80de\u764c\u306b\u5bfe\u3057\u3066\u5316\u5b66\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u65bd\u884c\u3057\u305f1\u4f8b. \u7b2c137\u56de\u3000\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u3000\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff082022\u5e7412\u6708\u3000\u5fb3\u5cf6\uff09<\/p>\n

24. \u68ee\u5ddd\u53cb\u90ce, \u6b66\u7530\u82f1\u6a39, \u771f\u934b\u4fca\u6cbb, \u677e\u7530\u82f1\u7950, \u4f50\u85e4\u5275, \u52a0\u85e4\u9ad8\u82f1, \u83ca\u6c60\u6cf0\u8f14, \u5742\u6771\u5065\u6b21. IgG4\u95a2\u9023\u547c\u5438\u5668\u75be\u60a3\u304c\u5f37\u304f\u7591\u308f\u308c\u305f\u5185\u90e8\u9020\u5f71\u4e0d\u826f\u57df\u3092\u4f34\u3046\u80ba\u708e\u75c7\u6027\u507d\u816b\u760d\u306e\uff12\u4f8b. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2022.12, \u5fb3\u5cf6)<\/p>\n

25. \u5c71\u672c\u5468\u5e73, \u85e4\u672c\u88d5, \u4e95\u4e0a\u7950\u99ac, \u539f\u4e95\u5ddd\u8c4a\u7ae0, \u7af9\u53e3\u5d07, \u77f3\u5ddd\u6d69\u53f2, \u798f\u4e95\u8061, \u77f3\u7530\u76f4\u6a39, \u9ebb\u751f\u5065\u4f0d, \u677e\u5f71\u662d\u4e00. \u9ac4\u819c\u816b\u8853\u5f8c\u7d4c\u904e\u4e2d\u306b\u809d\u8ee2\u79fb\uff0c\u9aa8\u8ee2\u79fb\u3092\u8a8d\u3081\u305f\u4e00\u4f8b. \u7b2c137\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a(2022.12.3-4, \u5fb3\u5cf6)<\/p>\n

26. \u671b\u6708\u7814\uff0c\u6728\u6751\u6d69\u4e4b, \u4f50\u85e4\u54f2\u4e5f, \u68b6\u539f \u7be4,\u5cf6\u6d25\u6210\u7ae0, \u7389\u4e95\u8cb4\u57fa , \u85e4\u539f\u653f\u7d14, \u6d25\u7530\u662d\u6d0b\uff0c\u570b\u5ef6\u62d3\u771f\uff0c\u7530\u4e2d\u4f38\u53f8. \u5f53\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308bFDP\u642d\u8f09\u80c3\u90e8\u691c\u8a3a\u8eca\u306e\u5c0e\u5165\u306b\u3064\u3044\u3066. \u7b2c39\u56de\u56db\u56fd\u8fb2\u6751\u533b\u5b66\u4f1a\uff082022.7.24, \u9ad8\u77e5\uff09<\/p>\n

27. \u4f50\u85e4\u54f2\u4e5f, \u5bfa\u5742\u5229\u9999, \u68b6\u539f\u7be4\uff0c\u5468\u9632\u9999\u6d25\u4e16, \u6e9d\u7530\u6d0b\u5b50, \u57ce\u6238\u667a\u5b50\uff0c\u6fa4\u980c\u5b50\uff0c\u7530\u4e2d\u4f38\u53f8. \u5927\u8178CT\u691c\u67fb\u306b\u304a\u3051\u308b\u5927\u8178\u61a9\u5ba4\u3068\u5927\u8178\u62e1\u5f35\u306e\u95a2\u4fc2\u306b\u3064\u3044\u3066. \u7b2c53\u56de\u65e5\u672c\u6d88\u5316\u5668\u304c\u3093\u691c\u8a3a\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\uff082022.11.26-27\uff0c\u5cf6\u6839\uff09<\/p>\n

 <\/p>\n

\u25a0<\/span> \u8b1b\u6f14<\/strong><\/p>\n

1. \u4e95\u624b\u9999\u5948. \u547c\u5438\u7642\u6cd5\u30bb\u30df\u30ca\u30fc 1\u3000\u547c\u5438\u4e0d\u5168\u3068\u753b\u50cf\u8a3a\u65ad. \u65e5\u672c\u533b\u5de5\u5b66\u6cbb\u7642\u5b66\u4f1a\u7b2c38\u56de\u5b66\u8853\u5927\u4f1a. (2022.5, \u677e\u5c71)<\/p>\n

2. \u4e95\u4e0a\u3000\u6b66. RI\u5185\u7528\u7642\u6cd5\u306e\u6b74\u53f2\u3068\u4eca\u5f8c\u306e\u5c55\u671b. NET Web Seminar 2022. (202. 12)<\/p>\n

3. \u5ddd\u53e3\u76f4\u4eba. \u5f53\u79d1\u306b\u304a\u3051\u308b\u82e5\u624b\u7814\u7a76\u8cbb\u7372\u5f97\u306e\u5b9f\u969b.\u3000\u79d1\u7814\u8cbb\u306e\u7372\u5f97\u3068\u57f7\u884c\u7b49\u306b\u95a2\u3059\u308b\u8aac\u660e\u4f1a\uff082022.7, \u611b\u5a9b\u5927\u5b66\uff09<\/p>\n

4. \u5ddd\u53e3\u76f4\u4eba. \u30c0\u30a4\u30ca\u30df\u30c3\u30af\u5fc3\u7b4b\u8840\u6d41 SPECT \u306b\u3088\u308b\u5c40\u6240\u865a\u8840\u75c5\u5909\u306e\u5b9a\u91cf\u8a55\u4fa1\u306e\u53ef\u80fd\u6027.\u3000\u7b2c16\u56deCZT-SPECT\u7814\u7a76\u4f1a\uff082022.12, Web\uff09<\/p>\n

5. \u57ce\u6238\u502b\u4e4b. \u5fc3\u7b4b\u8840\u6d41\u30fb\u8840\u6d41\u4e88\u5099\u80fd\u3068\u8ca0\u8377\u691c\u67fb. \u7b2c13\u56deSCMR Japan WG Seminar \u3000\u6559\u80b2\u8b1b\u6f14\uff082022. 1, \u4e09\u91cd\uff09<\/p>\n

6. \u57ce\u6238\u502b\u4e4b. \u5fc3\u81d3MRI\u306e\u6700\u524d\u7dda. \u7b2c32\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\u3000\u6559\u80b2\u8b1b\u6f14\u3000\uff082022. 5, \u6771\u4eac\uff09<\/p>\n

7. \u57ce\u6238\u502b\u4e4b. \u5fc3\u4e0d\u5168\u8a3a\u7642\u306b\u4f34\u8d70\u3059\u308b\u653e\u5c04\u7dda\u8a3a\u65ad. \u5faa\u74b0\u5668Care Pathway\u52c9\u5f37\u4f1a \u6559\u80b2\u8b1b\u6f14\u3000\uff082022. 7, WEB\uff09<\/p>\n

8. \u57ce\u6238\u502b\u4e4b. \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u8a3a\u65ad\uff1aCine MRI, LGE MRI. \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u753b\u50cf\u8a3a\u65ad\u3000\u6559\u80b2\u8b1b\u6f14\uff082022. 7, \u6771\u4eac\uff09<\/p>\n

9. \u57ce\u6238\u502b\u4e4b. MINOCA. \u7b2c14\u56deSCMR Japan WG Seminar\u3000\u6559\u80b2\u8b1b\u6f14\u3000\uff082022. 7, \u6771\u4eac\uff09<\/p>\n

10. \u57ce\u6238\u502b\u4e4b. \u5727\u7e2e\u30bb\u30f3\u30b7\u30f3\u30b0\u3092\u7528\u3044\u305f\u5fc3\u81d3MRI\u64ae\u50cf\u306e\u9ad8\u901f\u5316. \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u6559\u80b2\u8b1b\u6f14\u3000\uff082022. 9, \u611b\u77e5\uff09<\/p>\n

11. \u57ce\u6238\u502b\u4e4b. \u300e\u5148\u751f\u3001\u305d\u308c\u5fc3\u81d3MRI\u3067\u5206\u304b\u308a\u307e\u3059\u3088\u300f. \u7b2c63\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u30a4\u30d6\u30cb\u30f3\u30b0\u30bb\u30df\u30ca\u30fc\u3000\uff082022. 10, \u6a2a\u6d5c\uff09<\/p>\n

12. \u57ce\u6238\u502b\u4e4b. \u9ad8\u901f\u64ae\u50cf\u6cd5. \u7b2c26\u56deMR\u5b9f\u8df5\u30fb\u5148\u7aef\u8b1b\u5ea7\uff62\u5fc3\u8840\u7ba1\u9818\u57dfMRI\uff63\u3000\u6559\u80b2\u8b1b\u6f14\uff082022. 12, WEB\uff09<\/p>\n

13. \u83c5\u539f\u656c\u6587\uff0e\u6559\u80b2\u8b1b\u6f1432\u3000\u4e73\u623f2\uff1a\u4e73\u623f\u753b\u50cf\u8a3a\u65ad\u306eTips & Pitfalls\u2461\u3000\u4e73\u764c\u306b\u304a\u3051\u308bFDG-PET\/CT\uff0e\u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082022.4.14-17\uff0c\u6a2a\u6d5c\uff0cHybrid\uff09<\/p>\n

14. \u7530\u908a\u88d5\u8cb4\u3000CT imaging of Vulnerable Plaque \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12 Beyond angiography Japan XX\u2165\u3000\uff082022\u5e743\u6708\u3000Web\uff09<\/p>\n

15. \u7530\u908a\u88d5\u8cb4\u3000\u5fc3\u81d3CT\u306e\u57fa\u672c\u3068\u8aad\u5f71\u306e\u30dd\u30a4\u30f3\u30c8\u3000\u6559\u80b2\u8b1b\u6f14\u3000\u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff082022\u5e749\u6708\u3000\u6771\u4eac\uff09<\/p>\n

16. \u7530\u908a\u88d5\u8cb4\u3000Area Detector CT\u306b\u304a\u3051\u308b\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\u306e\u65b0\u30a2\u30d7\u30ed\u30fc\u30c1\u3000\u4e5d\u5dde\u30ad\u30e3\u30ce\u30f3CT\u30e6\u30fc\u30b6\u30fc\u4f1a\uff082022\u5e749\u6708\u3000Web\uff09<\/p>\n

17. \u974d\u5ca1\u614e\u592a\u90ce\uff0e\u611b\u5a9b\u5927\u5b66\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u5be1\u5206\u5272\u7167\u5c04\u306e\u521d\u671f\u7d4c\u9a13\uff0e\u56db\u56fd\u653e\u5c04\u7dda\u6cbb\u7642Web Seminar (2022. 11, Web)<\/p>\n

18. \u6771\u91ce \u535a. \u5fc3\u7b4b\u8840\u6d41\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u8aad\u5f71\u3068\u30ec\u30dd\u30fc\u30c8\u4f5c\u6210. \u7b2c15\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u533a\u5730\u57df\u5225\u6559\u80b2\u7814\u4fee\u4f1a\u30012022\u5e7411\u67085\u65e5\u3001\u9ad8\u677e\u30bb\u30f3\u30bf\u30fc\u30d3\u30eb.<\/p>\n

19. \u5e73\u585a\u7fa9\u5eb7. \u653e\u5c04\u7dda\u306e\u57fa\u790e. \u611b\u5a9b\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u57fa\u790e\u7814\u4fee. (2022. 9, Web)<\/p>\n

20. \u5e73\u585a\u7fa9\u5eb7. \u653e\u5c04\u7dda\u306e\u5f71\u97ff. \u611b\u5a9b\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u57fa\u790e\u7814\u4fee. (2022. 9, Web)<\/p>\n

21. \u5e73\u585a\u7fa9\u5eb7. \u81b5\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u8a3a\u65ad\u3068\u65b0\u305f\u306a\u6cbb\u7642. \u611b\u5a9b\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u304c\u3093\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc \u7b2c30\u56de\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7. (2022. 11, Web)<\/p>\n

22. \u5bae\u5ddd\u6b63\u7537. \u6559\u80b2\u8b1b\u6f14\uff1b\u5fc3\u81d3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u753b\u50cf\u8a3a\u65ad\u6cd5\u306e\u6700\u8fd1\u306e\u9032\u6b69\uff1aF-18 FDG PET\/CT\u3092\u4e2d\u5fc3\u306b. \u7b2c62\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2022. 9, \u4eac\u90fd)<\/p>\n

23. \u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14\uff1b\u6162\u6027\u51a0\u75c7\u5019\u7fa4\u306b\u304a\u3051\u308b\u5fc3\u81d3\u6838\u533b\u5b66\u306e\u73fe\u72b6\u3068\u5c06\u6765\u5c55\u671b. \u7b2c32\u56de\u706b\u306e\u56fdRI\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2022. 2, \u718a\u672c)<\/p>\n

24. \u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14\uff1b\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u30b9\uff1aTheranostics\u3068\u5fc3\u81d3\u6838\u533b\u5b66. \u7b2c46\u56de\u611b\u5a9b\u6838\u533b\u5b66\u61c7\u8a71\u4f1a (2022. 11, \u677e\u5c71)<\/p>\n

25. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u306e\u9632\u8b77\u63aa\u7f6e\u3068\u3057\u3066\u306e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306b\u3064\u3044\u3066. \u4ee4\u548c\uff13\u5e74\u5ea6\u77f3\u5ddd\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\uff082022\uff0e1\uff0eWEB\uff09<\/p>\n

26. \u5c71\u672c\u5c1a\u5e78\uff0eResponse at facilities outside medical institutions in radiation disaster-Focus on education and training. \u30d5\u30a7\u30cb\u30c3\u30af\u30b9\u30d7\u30ed\u30b0\u30e9\u30e0\uff082022\uff0e1\uff0e\u5e83\u5cf6\uff09<\/p>\n

27. \u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u306e\u57fa\u790e\u77e5\u8b58\u3068\u4eba\u4f53\u3078\u306e\u5f71\u97ff\u53ca\u3073\u539f\u5b50\u529b\u707d\u5bb3\u306e\u57fa\u790e\u77e5\u8b58. \u4ee4\u548c\uff13\u5e74\u5ea6\u65b0\u6f5f\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a\uff082022\uff0e1\uff0eWeb\uff09<\/p>\n

28. \u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u304a\u3088\u3073\u539f\u5b50\u529b\u707d\u5bb3\u306e\u57fa\u790e\u3068\u6c5a\u67d3\u50b7\u75c5\u8005\u642c\u9001\u306b\u304a\u3051\u308b\u6ce8\u610f\u70b9. \u65e5\u672c\u539f\u71c3JET\u52c9\u5f37\u4f1a\uff082022\uff0e2\uff0e\u516d\u30b1\u6240\u6751\uff09<\/p>\n

29. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u5354\u529b\u6a5f\u95a2\u306e\u5f79\u5272\u306b\u3064\u3044\u3066. \u9e7f\u5150\u5cf6\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u691c\u8a0e\u4f1a\u533b\u7642\u4f5c\u696d\u90e8\u4f1a\uff082022\uff0e2\uff0e\u9e7f\u5150\u5cf6\uff09<\/p>\n

30. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u6700\u8fd1\u306e\u52d5\u5411\u306b\u3064\u3044\u3066. \u4eac\u90fd\u5927\u5b66\u88ab\u3070\u304f\u533b\u7642\u30b7\u30ea\u30fc\u30ba\u8b1b\u6f14\u4f1a\uff082022\uff0e3\uff0e\u4eac\u90fd\uff09<\/p>\n

31. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c\u3001\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc\uff0e\u4ee4\u548c4\u5e74\u5ea6\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306b\u95a2\u3059\u308b\u533b\u7642\u5f93\u4e8b\u8005\u5411\u3051\u7814\u4fee\u4f1a\uff082022 6\uff0eWEB\uff09<\/p>\n

32. \u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u306e\u304a\u306f\u306a\u3057 \u4ee4\u548c\uff14\u5e74\u5ea6\u8eab\u306e\u56de\u308a\u306e\u653e\u5c04\u7dda\u6e2c\u5b9a\u4f53\u9a13\u6559\u5ba4\uff082022\uff0e8\uff0e\u677e\u5c71\uff09<\/p>\n

33. \u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u7dcf\u8ad6\u3001\u539f\u5b50\u529b\u707d\u5bb3\u7dcf\u8ad6. \u5317\u6d77\u9053\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a\uff082022\uff0e9\uff0e\u5c0f\u6a3d\uff09<\/p>\n

34. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u907f\u96e3\u9000\u57df\u6642\u691c\u67fb\u304a\u3088\u3073\u7c21\u6613\u9664\u67d3\uff0e\u4ee4\u548c4\u5e74\u5ea6\u5317\u6d77\u9053\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a\uff082022.10\uff0e\u672d\u5e4c\uff09<\/p>\n

35. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u7dca\u6025\u914d\u5e03\u306b\u3064\u3044\u3066\uff0e\u4ee4\u548c4\u5e74\u5ea6\u611b\u5a9b\u770c\u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u533b\u7642\u6d3b\u52d5\u7814\u4fee\uff082022.10\u3001\u516b\u5e61\u6d5c\u5e02\uff09<\/p>\n

36. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c\u3001\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc\uff0e\u4ee4\u548c4\u5e74\u5ea6\u4f50\u8cc0\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u57fa\u790e\u7814\u4fee\uff082022.10\u3001\u4f50\u8cc0\u5e02\uff09<\/p>\n

37. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u907f\u96e3\u9000\u57df\u6642\u691c\u67fb\u53ca\u3073\u7c21\u6613\u9664\u67d3\u3001\u653e\u5c04\u7dda\u6e2c\u5b9a\u5668\u53ca\u3073\u500b\u4eba\u7dda\u91cf\u8a08\u306e\u53d6\u6271\uff0e\u4ee4\u548c4\u5e74\u5ea6\u798f\u4e95\u770c\u539f\u5b50\u529b\u9632\u707d\u500b\u5225\u7814\u4fee\uff08\u907f\u96e3\u9000\u57df\u6642\u691c\u67fb\u53ca\u3073\u7c21\u6613\u9664\u67d3\uff09\uff082022.10\u3001\u6566\u8cc0\u5e02\uff09<\/p>\n

38. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c\u3001\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc\uff0e\u4ee4\u548c4\u5e74\u5ea6\u798f\u4e95\u770c\u539f\u5b50\u529b\u9632\u707d\u500b\u5225\u7814\u4fee\uff08\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7dca\u6025\u914d\u5e03\uff09\uff082022.10\u3001\u6566\u8cc0\u5e02\uff09<\/p>\n

 <\/p>\n

\u25a0<\/span> \u7814\u7a76\u52a9\u6210<\/strong><\/p>\n

1. \u57ce\u6238\u502b\u4e4b. \u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a\u3000\u79d1\u7814\u8cbb\u3000\u57fa\u76e4\u7814\u7a76C\u3000\u5727\u7e2e\u30bb\u30f3\u30b7\u30f3\u30b0\u3092\u5fdc\u7528\u3057\u305f\u51a0\u52d5\u8108MRA\u9ad8\u901f\u64ae\u50cf\u6cd5\u306e\u958b\u767a\u3000\uff08\u4ee4\u548c3\u5e74\u5ea6-\u4ee4\u548c5\u5e74\u5ea6\u3000\u7814\u7a76\u4ee3\u8868\u8005\uff09<\/p>\n

2. \u974d\u5ca1\u614e\u592a\u90ce\uff0e\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a \u79d1\u7814\u8cbb \u82e5\u624b\u7814\u7a76 \u80f8\u90e8IMRT\u65bd\u884c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u5fc3\u81d3MRI\u3092\u7528\u3044\u305f\u5fc3\u6bd2\u6027\u8a55\u4fa1\u3068\u5fc3\u81d3\u7dda\u91cf\u5236\u7d04\u306e\u78ba\u7acb (\u4ee4\u548c4\u5e74\uff5e\u4ee4\u548c6\u5e74 \u7814\u7a76\u4ee3\u8868\u8005)<\/p>\n

3. \u5409\u7530\u548c\u6a39. \u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a\u3000\u79d1\u7814\u8cbb \u82e5\u624b\u7814\u7a764D-similarity filter \u3092\u5fdc\u7528\u3057\u305f\u4f4e\u4fb5\u8972\u5fc3\u7b4b CTP \u958b\u767a (\u4ee4\u548c4\u5e74\u5ea6-\u4ee4\u548c5\u5e74\u5ea6\u3000\u7814\u7a76\u4ee3\u8868\u8005\uff09<\/p>\n

4. \u5bae\u5ddd\u6b63\u7537.\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a \u79d1\u7814\u8cbb \u30c7\u30b8\u30bf\u30ebPET\/CT\u306b\u3088\u308b\u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u304a\u3088\u3073\u8840\u7ba1\u5468\u56f2\u8102\u80aa\u7d44\u7e54\u306e\u708e\u75c7\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0 \u57fa\u76e4\u7814\u7a76(C) (2020\u5e74\uff5e2022\u5e74\u3000\u7814\u7a76\u4ee3\u8868\u8005)<\/p>\n

 <\/p>\n

\u25a0<\/span>\u00a0\u53d7\u8cde<\/strong><\/p>\n

1. \u5ca1\u7530\u77e5\u4e45. \u7b2c\uff18\uff11\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u30a4\u30e1\u30fc\u30b8\u30fb\u30a4\u30f3\u30bf\u30fc\u30d7\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3 \u7b2c\uff13\u4f4d\u5165\u8cde<\/p>\n

2. \u7267\u7530\u61b2\u4e8c. \u7b2c13\u56de \u611b\u5a9b\u533b\u5b66\u4f1a\u5968\u52b1\u8cde<\/p>\n","protected":false},"template":"","class_list":["post-6370","results","type-results","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/results\/6370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/results"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/types\/results"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/media?parent=6370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}